Propylene Glycol/Glycerol Intake and Cardiorespiratory Function

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2020

Conditions
Lung Injury
Interventions
OTHER

Nicotine free intake

The participant will wean off nicotine during five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.

OTHER

Nicotine intake

The participant will pursuit his regular nicotinic propylene/glycerol intake five days before the experimental session. At the start of the experimental session, participants will be exposed to acute propylene glycol/glycerol (mix 50:50) intake.

OTHER

Cessation intake

The participant will completely stop his regular nicotinic propylene/glycerol intake during five days before the session. At the start of the experimental session, participants will mimick intake with the device turns off.

Trial Locations (1)

1070

Erasme Hospital, Brussels

All Listed Sponsors
lead

Université Libre de Bruxelles

OTHER

NCT03410511 - Propylene Glycol/Glycerol Intake and Cardiorespiratory Function | Biotech Hunter | Biotech Hunter